Skip to main content
Fig. 3 | Orphanet Journal of Rare Diseases

Fig. 3

From: Long-term efficacy of lipoprotein apheresis and lomitapide in the treatment of homozygous familial hypercholesterolemia (HoFH): a cross-national retrospective survey

Fig. 3

Individual yearly on-treatment LDL-C levels in Lomitapide and LA cohort. Individual yearly on-treatment LDL-C has been calculated as the average of yearly LDL-C measurements. In A are reported data in the Lomitapide cohort whereas in B those in the LA cohort. LDL-C, low density lipoprotein cholesterol; LA, Lipoprotein apheresis

Back to article page

Orphanet Journal of Rare Diseases

ISSN: 1750-1172